A new urine test performed better than PSA-based testing and MRI for monitoring low-risk prostate cancers on active ...
Medical Device Network on MSN
FDA clears Bright Uro’s abdominal sensor for evaluating bladder dysfunction
The approval of Bright Uro’s Glean abdominal sensor advances the capabilities of its broader Glean urodynamics system that ...
The United States Food and Drug Administration recently approved Sotyktu TM (deucravacitinib) for the treatment of active psoriatic arthritis (PsA) among adults. Which of the statements below about ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results